Carfilzomib: Looking for ‘The Holy Grail’ to treat antibody‐mediated rejection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Carfilzomib: Looking for ‘The Holy Grail’ to treat antibody‐mediated rejection

Published:2023-05-02 Issue:7 Volume:27 Page:
ISSN:1397-3142
Container-title:Pediatric Transplantation
language:en
Short-container-title:Pediatric Transplantation

Author:

Laroche Camille¹,Marks Stephen D.¹²^ORCID

Affiliation:

1. Department of Paediatric Nephrology Great Ormond Street Hospital for Children NHS Foundation Trust London UK

2. NIHR Great Ormond Street Hospital Biomedical Research Centre University College London Great Ormond Street Institute of Child Health London UK

Publisher

Wiley

Subject

Transplantation,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/petr.14533

Reference14 articles.

1. Kidney transplant practice patterns and outcome benchmarks over 30 years: The 2018 report of the NAPRTCS

2. North American Pediatric Renal Trials and Collaborative Studies NAPRTCS (2014) Annual Transplant Report.2014. Accessed April 11 2023.www.naprtcs.org. Via webpage available athttps://naprtcs.org/system/files/2014_Annual_Transplant_Report.pdf

3. Treatment strategies to treat antibody-mediated rejection and to reduce donor-specific antibodies

4. One-year Results of the Effects of Rituximab on Acute Antibody-Mediated Rejection in Renal Transplantation

5. The Treatment of Antibody-Mediated Rejection in Kidney Transplantation

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP